Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (

RNA sequencing TERT promoter C228T and C250T mutations differential gene expression analysis pan-cancer investigation pathway activation profiling reverse transcriptase

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2024
Historique:
received: 18 03 2024
accepted: 08 05 2024
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 11 6 2024
Statut: epublish

Résumé

The

Identifiants

pubmed: 38859942
doi: 10.3389/fgene.2024.1401100
pii: 1401100
pmc: PMC11163056
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1401100

Informations de copyright

Copyright © 2024 Drobyshev, Modestov, Suntsova, Poddubskaya, Seryakov, Moisseev, Sorokin, Tkachev, Zakharova, Simonov, Zolotovskaia and Buzdin.

Déclaration de conflit d'intérêts

Author VT was employed by the Oncobox LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Aleksey Drobyshev (A)

Endocrinology Research Center, Moscow, Russia.
Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Alexander Modestov (A)

Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Maria Suntsova (M)

Endocrinology Research Center, Moscow, Russia.
Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Elena Poddubskaya (E)

Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Clinical Center Vitamed, Moscow, Russia.

Alexander Seryakov (A)

Medical Holding SM-Clinic, Moscow, Russia.

Aleksey Moisseev (A)

Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Maksim Sorokin (M)

Endocrinology Research Center, Moscow, Russia.
Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Victor Tkachev (V)

Oncobox LLC, Moscow, Russia.

Galina Zakharova (G)

Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Aleksander Simonov (A)

Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.

Marianna A Zolotovskaia (MA)

Endocrinology Research Center, Moscow, Russia.
Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Moscow Center for Advanced Studies 20, Moscow, Russia.

Anton Buzdin (A)

Endocrinology Research Center, Moscow, Russia.
Institute of Personalized Oncology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Moscow Center for Advanced Studies 20, Moscow, Russia.
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Classifications MeSH